NanoPoreFab (coordinator, SME-1) focused specifically on on-chip fabrication of solid-state nanopores, placing this at the core of their commercial offering.
IONERA TECHNOLOGIES GMBH
Freiburg SME developing on-chip solid-state nanopores for high-throughput single molecule analysis and precision polymer characterization.
Their core work
Ionera Technologies is a Freiburg-based deep-tech SME specializing in the fabrication of solid-state nanopores — engineered nanoscale apertures in thin membranes or chips — used to detect and analyze individual molecules at high throughput. Their NanoPoreFab project, which they led as coordinator, focused on developing on-chip fabrication of these structures for single molecule analysis, indicating a product-development orientation rather than pure research. Their participation in the EURO-SEQUENCES training network on sequence-controlled synthetic polymers suggests they also apply nanopore-based methods to the characterization of precision polymer architectures. In practical terms, they occupy a niche where semiconductor-style nanofabrication meets molecular biophysics and advanced materials analysis.
What they specialise in
NanoPoreFab targeted high-throughput single molecule analysis as the application domain for their nanopore chip technology.
Participation in EURO-SEQUENCES, an MSCA training network on monomer sequence control in polymers and next-generation precision materials, suggests capability in characterizing synthetic polymer architectures.
The on-chip framing of NanoPoreFab implies integration of nanopore structures into microfluidic or chip-based platforms, not just freestanding membrane fabrication.
How they've shifted over time
Both of Ionera's H2020 projects started in 2015, and no keyword metadata is available, which makes it impossible to trace a meaningful evolution in focus over time. What can be said is that in 2015 they were simultaneously pursuing foundational technology development (nanopore chip fabrication via their own SME-1 project) and embedding themselves in a broader scientific network around precision polymer materials (EURO-SEQUENCES). Whether their work has since shifted — for example toward commercial nanopore products, diagnostics, or polymer sequencing — cannot be determined from the available H2020 record alone.
With only two projects both initiated in 2015 and no subsequent H2020 activity on record, the trajectory beyond their early-stage commercialization push is unclear — a potential partner should verify their current product status and active research lines directly.
How they like to work
Ionera has acted both as coordinator (NanoPoreFab) and as participant (EURO-SEQUENCES), suggesting they are comfortable in either role depending on the project type — they lead when the project is directly about their own technology, and join as a specialist contributor when broader scientific networks are involved. Their overall network is small: 8 unique partners across just 2 projects implies they work in compact, focused consortia rather than large multi-stakeholder groupings. This profile is typical of early-stage deep-tech SMEs that collaborate selectively to protect IP while gaining scientific validation.
Ionera has collaborated with 8 unique partners spanning 5 countries, a modest but internationally distributed footprint consistent with a young SME building its first European partnerships. No dominant geographic cluster is apparent from the available data.
What sets them apart
Solid-state nanopore fabrication is a highly specialized capability held by very few commercial actors in Europe, and Ionera's SME-1 grant for NanoPoreFab signals that they were pursuing it as a product rather than a research curiosity. For a consortium builder, this means Ionera can potentially supply proprietary chip-based sensing components — not just know-how — which is a meaningfully different value proposition from academic nanopore groups. Their dual grounding in nanofabrication and precision polymer science also makes them a credible bridge between materials chemistry consortia and sensing or diagnostics projects.
Highlights from their portfolio
- NanoPoreFabCoordinated as an SME-1 feasibility grant — the most direct evidence of commercial product intent — focused on a technically demanding fabrication challenge with clear applications in molecular diagnostics and sequencing.
- EURO-SEQUENCESParticipation in a large MSCA Innovative Training Network on sequence-controlled polymers with EUR 249,216 in funding, indicating that Ionera's nanopore technology was considered relevant to characterizing next-generation synthetic materials.